Millimeter Dust Emission in the GQ Lup System

We present Submillimeter Array observations of the GQ Lup system at 1.3 millimeters wavelength with 0\farcs4 ($\sim$60 AU) resolution. Emission is detected from the position of the primary star, GQ Lup A, and is marginally resolved. No emission is detected from the substellar companion, GQ Lup B, 0\farcs7 away. These data, together with models of the spectral energy distribution, suggest a compact disk around GQ Lup A with mass $\sim 3$ M$_{Jup}$, perhaps truncated by tidal forces. There is no evidence for a gap or hole in the disk that might be the signature of an additional inner companion body capable of scattering GQ Lup B out to $\sim100$ AU separation from GQ Lup A. For GQ Lup B to have formed {\it in situ}, the disk would have to have been much more massive and extended.Comment: 16 pages, 2 figures, accepted to A

A New Probe of the Planet-Forming Region in T Tauri Disks

We present new observations of the FUV (1100-2200 Angstrom) radiation field and the near- to mid-IR (3--13.5 micron) spectral energy distribution (SED) of a sample of T Tauri stars selected on the basis of bright molecular disks (GM Aur, DM Tau, LkCa15). In each source we find evidence for Ly alpha induced H2 fluorescence and an additional source of FUV continuum emission below 1700 Angstroms. Comparison of the FUV spectra to a model of H2 excitation suggests that the strong continuum emission is due to electron impact excitation of H2. The ultimate source of this excitation is likely X-ray irradiation which creates hot photo-electrons mixed in the molecular layer. Analysis of the SED of each object finds the presence of inner disk gaps with sizes of a few AU in each of these young (~1 Myr) stellar systems. We propose that the presence of strong H2 continuum emission and inner disk clearing are related by the increased penetration power of high energy photons in gas rich regions with low grain opacity.Comment: 5 pages, 3 figures, accepted by ApJ Letter

Confirmation of a recent bipolar ejection in the very young hierarchical multiple system IRAS 16293-2422

We present and analyze two new high-resolution (approx 0.3 arcsec), high-sensitivity (approx 50 uJy beam-1) Very Large Array 3.6 cm observations of IRAS 16293-2422 obtained in 2007 August and 2008 December. The components A2alpha and A2beta recently detected in this system are still present, and have moved roughly symmetrically away from source A2 at a projected velocity of 30-80 km s-1. This confirms that A2alpha and A2beta were formed as a consequence of a very recent bipolar ejection from A2. Powerful bipolar ejections have long been known to occur in low-mass young stars, but this is -to our knowledge-- the first time that such a dramatic one is observed from its very beginning. Under the reasonable assumption that the flux detected at radio wavelengths is optically thin free-free emission, one can estimate the mass of each ejecta to be of the order of 10^-8 Msun. If the ejecta were created as a consequence of an episode of enhanced mass loss accompanied by an increase in accretion onto the protostar, then the total luminosity of IRAS 16293-2422 ought to have increased by 10-60% over the course of at least several months. Between A2alpha and A2beta, component A2 has reappeared, and the relative position angle between A2 and A1 is found to have increased significantly since 2003-2005. This strongly suggests that A1 is a protostar rather than a shock feature, and that the A1/A2 pair is a tight binary system. Including component B, IRAS 16293-2422 therefore appears to be a very young hierarchical multiple system.Comment: Accepted for publication in The Astrophysical Journa

Resolving the CO Snow Line in the Disk around HD 163296

We report Submillimeter Array (SMA) observations of CO (J=2--1, 3--2 and 6--5) and its isotopologues (13CO J=2--1, C18O J=2--1 and C17O J=3--2) in the disk around the Herbig Ae star HD 163296 at ~2" (250 AU) resolution, and interpret these data in the framework of a model that constrains the radial and vertical location of the line emission regions. First, we develop a physically self-consistent accretion disk model with an exponentially tapered edge that matches the spectral energy distribution and spatially resolved millimeter dust continuum emission. Then, we refine the vertical structure of the model using wide range of excitation conditions sampled by the CO lines, in particular the rarely observed J=6--5 transition. By fitting 13CO data in this structure, we further constrain the vertical distribution of CO to lie between a lower boundary below which CO freezes out onto dust grains (T ~ 19 K) and an upper boundary above which CO can be photodissociated (the hydrogen column density from the disk surface is ~ 10^{21} cm-2). The freeze-out at 19 K leads to a significant drop in the gas-phase CO column density beyond a radius of ~155 AU, a "CO snow line" that we directly resolve. By fitting the abundances of all CO isotopologues, we derive isotopic ratios of 12C/13C, 16O/18O and 18O/17O that are consistent with quiescent interstellar gas-phase values. This detailed model of the HD 163296 disk demonstrates the potential of a staged, parametric technique for constructing unified gas and dust structure models and constraining the distribution of molecular abundances using resolved multi-transition, multi-isotope observations.Comment: 40 pages, 13 figures, accepted for publication in Ap

Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program

Background: Metabolic syndrome is characterized as the co-occurrence of interrelated cardiovascular risk factors, including insulin resistance, hyperinsulinemia, abdominal obesity, dyslipidemia and hypertension. Once weekly tirzepatide is approved in the US and EU for the treatment of type 2 diabetes (T2D) and obesity. In the SURPASS clinical trial program for T2D, tirzepatide demonstrated greater improvements in glycemic control, body weight reduction and other cardiometabolic risk factors versus placebo, subcutaneous semaglutide 1 mg, insulin degludec, and insulin glargine. This post hoc analysis assessed the effect of tirzepatide use on the prevalence of patients meeting the criteria for metabolic syndrome across SURPASS 1–5. Methods: Metabolic syndrome was defined as having ≥ 3 of 5 criteria according to the US National Cholesterol Education Program: Adult Treatment Panel III. Analyses were based on on-treatment data at the primary endpoint from patients adherent to treatment (taking ≥ 75% study drug). A logistic regression model with metabolic syndrome status as the response variable, metabolic syndrome status at the baseline visit as an adjustment, and randomized treatment as fixed explanatory effect was used. The effect of tirzepatide use on the prevalence of patients meeting the criteria for metabolic syndrome by categorical weight loss, background medication and gender were assessed. Results: In SURPASS, the prevalence of patients meeting the criteria for metabolic syndrome at baseline was 67–88% across treatment groups with reductions at the primary endpoint to 38–64% with tirzepatide versus 64–82% with comparators. Reductions in the prevalence of patients meeting the criteria for metabolic syndrome was significantly greater with all tirzepatide doses versus placebo, semaglutide 1 mg, insulin glargine, and insulin degludec (p < 0.001). Individual components of metabolic syndrome were also reduced to a greater extent with tirzepatide vs comparators. Greater reductions in body weight were associated with greater reductions in the prevalence of patients meeting the criteria for metabolic syndrome and its individual components. Background SGLT2i or sulfonylurea use or gender did not impact the change in prevalence of patients meeting the criteria for metabolic syndrome. Conclusions: In this post hoc analysis, tirzepatide at all doses studied was associated with a greater reduction in the prevalence of patients meeting the criteria for metabolic syndrome compared to placebo, semaglutide 1 mg, insulin degludec, and insulin glargine. Although more evidence is needed, these data would support greater potential improvement in cardiovascular risk factor profile with tirzepatide treatment in people across the continuum of T2D

Chemical Imaging of the CO Snow Line in the HD 163296 Disk

The condensation fronts (snow lines) of H2O, CO, and other abundant volatiles in the midplane of a protoplanetary disk affect several aspects of planet formation. Locating the CO snow line, where the CO gas column density is expected to drop substantially, based solely on CO emission profiles, is challenging. This has prompted an exploration of chemical signatures of CO freeze-out. We present ALMA Cycle 1 observations of the N2H+ J = 3−2 and DCO+ J = 4−3 emission lines toward the disk around the Herbig Ae star HD 163296 at ~0farcs5 (60 AU) resolution, and evaluate their utility as tracers of the CO snow line location. The N2H+ emission is distributed in a ring with an inner radius at 90 AU, corresponding to a midplane temperature of 25 K. This result is consistent with a new analysis of optically thin C18O data, which implies a sharp drop in CO abundance at 90 AU. Thus N2H+ appears to be a robust tracer of the midplane CO snow line. The DCO+ emission also has a ring morphology, but neither the inner nor the outer radius coincide with the CO snow line location of 90 AU, indicative of a complex relationship between DCO+ emission and CO freeze-out in the disk midplane. Compared to TW Hya, CO freezes out at a higher temperature in the disk around HD 163296 (25 versus 17 K in the TW Hya disk), perhaps due to different ice compositions. This highlights the importance of actually measuring the CO snow line location, rather than assuming a constant CO freeze-out temperature for all disks.Astronom

The TW Hya Disk at 870 microns: Comparison of CO and Dust Radial Structures

We present high resolution (0.3" = 16 AU), high signal-to-noise ratio Submillimeter Array observations of the 870 microns (345 GHz) continuum and CO J=3--2 line emission from the protoplanetary disk around TW Hya. Using continuum and line radiative transfer calculations, those data and the multiwavelength spectral energy distribution are analyzed together in the context of simple two-dimensional parametric disk structure models. Under the assumptions of a radially invariant dust population and (vertically integrated) gas-to-dust mass ratio, we are unable to simultaneously reproduce the CO and dust observations with model structures that employ either a single, distinct outer boundary or a smooth (exponential) taper at large radii. Instead, we find that the distribution of millimeter-sized dust grains in the TW Hya disk has a relatively sharp edge near 60 AU, contrary to the CO emission (and optical/infrared scattered light) that extends to a much larger radius of at least 215 AU. We discuss some possible explanations for the observed radial distribution of millimeter-sized dust grains and the apparent CO-dust size discrepancy, and suggest that they may be hallmarks of substructure in the dust disk or natural signatures of the growth and radial drift of solids that might be expected for disks around older pre-main sequence stars like TW Hya.Comment: ApJ, in press (fixed typo in Equation 4

A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans

BACKGROUND: High fructose consumption is suspected to be causally linked to the epidemics of obesity and metabolic disorders. In rodents, fructose leads to insulin resistance and ectopic lipid deposition. In humans, the effects of fructose on insulin sensitivity remain debated, whereas its effect on ectopic lipids has never been investigated. OBJECTIVE: We assessed the effect of moderate fructose supplementation on insulin sensitivity (IS) and ectopic lipids in healthy male volunteers (n = 7). DESIGN: IS, intrahepatocellular lipids (IHCL), and intramyocellular lipids (IMCL) were measured before and after 1 and 4 wk of a high-fructose diet containing 1.5 g fructose . kg body wt(-1) . d(-1). Adipose tissue IS was evaluated from nonesterified fatty acid suppression, hepatic IS from suppression of hepatic glucose output (6,6-2H2-glucose), and muscle IS from the whole-body glucose disposal rate during a 2-step hyperinsulinemic euglycemic clamp. IHCL and IMCL were measured by 1H magnetic resonance spectroscopy. RESULTS: Fructose caused significant (P < 0.05) increases in fasting plasma concentrations of triacylglycerol (36%), VLDL-triacylglycerol (72%), lactate (49%), glucose (5.5%), and leptin (48%) without any significant changes in body weight, IHCL, IMCL, or IS. IHCL were negatively correlated with triacylglycerol after 4 wk of the high-fructose diet (r = -0.78, P < 0.05). CONCLUSION: Moderate fructose supplementation over 4 wk increases plasma triacylglycerol and glucose concentrations without causing ectopic lipid deposition or insulin resistance in healthy humans